Reappraisal of the diuretic effect of empagliflozin in the EMPA-REG OUTCOME trial: comparison with classic diuretics
AJ Scheen - Diabetes & metabolism, 2016 - Elsevier
Aims Empagliflozin, a sodium–glucose cotransporter type 2 (SGLT2) inhibitor, has been
associated with a remarkable reduction in cardiovascular and all-cause mortality in patients …
associated with a remarkable reduction in cardiovascular and all-cause mortality in patients …
Impact of tofogliflozin on hepatic outcomes: a systematic review
M Pathak, R Parveen, P Khan, N Saha… - European Journal of …, 2023 - Springer
Purpose Studies have demonstrated a high prevalence of non-alcoholic fatty liver disease
(NAFLD) in type 2 diabetes mellitus (T2DM) patients. The aim was to review the effect of …
(NAFLD) in type 2 diabetes mellitus (T2DM) patients. The aim was to review the effect of …
Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus
CJ Carlson, ML Santamarina - Expert Opinion on Drug Safety, 2016 - Taylor & Francis
Introduction: The safety profile of sodium-glucose cotransporter 2 (SGLT2) inhibitors has
continued to evolve with the availability of data from clinical trial programs, post-marketing …
continued to evolve with the availability of data from clinical trial programs, post-marketing …
A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus
KMP Kumar, S Ghosh, W Canovatchel… - Indian Journal of …, 2017 - journals.lww.com
Currently available antihyperglycemic agents, despite being effective, provide inadequate
glycemic control and/or are associated with side effects or nonadherence. Canagliflozin, a …
glycemic control and/or are associated with side effects or nonadherence. Canagliflozin, a …
Efficacy and safety of ertugliflozin in patients with type 2 diabetes inadequately controlled by metformin and sulfonylurea: a sub-study of VERTIS CV
Introduction VERTIS CV is the cardiovascular outcome trial for the sodium–glucose
cotransporter 2 (SGLT2) inhibitor ertugliflozin. A sub-study was conducted to assess the …
cotransporter 2 (SGLT2) inhibitor ertugliflozin. A sub-study was conducted to assess the …
Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
R Parveen, S Hussain, S Saini, P Khan… - Expert Opinion on …, 2024 - Taylor & Francis
ABSTRACT Introduction Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
is estimated to affect upto 70–80% of people with type 2 diabetes mellitus (T2DM). Although …
is estimated to affect upto 70–80% of people with type 2 diabetes mellitus (T2DM). Although …
[HTML][HTML] Drug-induced liver injury caused by Ipragliflozin administration with causality established by a positive lymphocyte transformation test (LTT) and the Roussel …
K Niijima, Y Niijima, S Okada, M Yamada - Annals of Hepatology, 2017 - Elsevier
A 75-year old male patient had been regularly visiting our hospital for the management of
his type 2 diabetes mellitus since he was diagnosed at age 64 years. When he developed …
his type 2 diabetes mellitus since he was diagnosed at age 64 years. When he developed …
Effects of Moringa oleifera seeds aqueous extract on type-II diabetic nephropathy in adult male albino rat
AF AL-BAYUOMI, NM MDv - The Medical Journal of Cairo University, 2021 - journals.ekb.eg
Background: Because of the potential antioxidant, anti-inflammatory, and immune-
modulating properties of Moringa oleifera, there is an increased interest in its potential …
modulating properties of Moringa oleifera, there is an increased interest in its potential …
A comparative study of canagliflozin (INVOKANA) on type-I and type-II diabetes mellitus on adult male albino rat
N Mabrouk Gabr, I Hassan Mohammed - Al-Azhar Medical Journal, 2020 - journals.ekb.eg
Background: Glycemic control is important in diabetes mellitus to minimize the progression
of the disease and the risk of potentially devastating complications. Inhibition of the sodium …
of the disease and the risk of potentially devastating complications. Inhibition of the sodium …
SGLT-2 inhibitors-hope or hype?-an updated review
RS Kumar - Asian Journal of Pharmaceutical Research, 2021 - indianjournals.com
SGLT-2 Inhibitors- Hope or Hype? - An updated Review Page 1 www.IndianJournals.com
Members Copy, Not for Commercial Sale Downloaded From IP - 66.249.68.82 on dated 1-Jul-2023 …
Members Copy, Not for Commercial Sale Downloaded From IP - 66.249.68.82 on dated 1-Jul-2023 …